T.‐C. Wu

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

K Y Lin, Frank Guarnieri, Kevin F. Staveley-O’Carroll et al. · PubMed · 1996 · 1K citations

Viral Immunity, Immunology, Novel Vaccine +19

Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.

Chien Hung Chen, Tian Li Wang, Chien‐Fu Hung et al. · PubMed · 2000 · 357 citations

Dna Vaccine Potency, Immunology, Immunodominance +16

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

T.‐C. Wu, Frank Guarnieri, Kevin F. Staveley-O’Carroll et al. · Proceedings of the National Academy of Sciences · 1995 · 347 citations · Full text

Histocompatibility, Class Ii, Adaptive Immune System +18

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

Wen‐Fang Cheng, Chien‐Fu Hung, Chee‐Yin Chai et al. · Journal of Clinical Investigation · 2001 · 249 citations · Full text

Immunology, Immunoediting, Crt Dna +17

Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens.

T.‐C. Wu, Risa B. Mann, J I Epstein et al. · PubMed · 1991 · 245 citations